로딩 중…
지수 로딩 중…
코미팜
041960· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩8,070-6.71%
2026-06-19
Price Chart
코미팜+59.49%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 596.26B KRW |
| Revenue | 49.99B KRW |
| Net Income | -3.27B KRW |
| Total Assets | 134.43B KRW |
| Net Assets | 73.32B KRW |
| Employees | 163 |
| Value | |
| P/B | 8.13x |
| P/S | 11.93x |
| FCF Yield | -0.62% |
| Profitability | |
| ROE | -4.45% |
| ROA | -2.43% |
| Op. Margin | -0.90% |
| Revenue Growth | -17.15% |
| Earnings Growth | 1370.94% |
| Financial Health | |
| Debt Ratio | 183.34% |
| Total Debt | 39.62B KRW |
| FCF | -3.71B KRW |
| Cash | 18.58B KRW |
| Current Ratio | 1.31x |
| Performance | |
| 1Y Return | 59.49% |
| 1M Return | 5.91% |
| From 52W High | -25.21% |
| 1Y MDD | -33.85% |
| Trading | |
| Volume | 324,145 shares |
| Foreign Own. | 4.30% |
| Per Share | |
| EPS | -88 KRW |
| BPS | 985 KRW |
Company Info
Established in 1972 for animal pharmaceutical manufacturing and sales, the company was listed on KOSDAQ in 2001 and produces vaccines and therapeutics at its Siheung-si and Yesan-gun factories. It engages in animal pharmaceutical manufacturing and offers virus and genetic testing research services, conducting overseas business through its subsidiaries. The company expanded its business areas by developing the new drug COMINOX, completing its Osong Bio-complex factory, and obtaining KGMP approval. It is now focused on global sales through a multinational pipeline. COMI Pharm was established in 1972 and is headquartered in Siheung-si, Gyeonggi-do.